Urine is the new blood

Pr Ivan Tack is a nephrologist and physiologist. Since 2006, he is Head of the Clinical Physiology Department at Rangueil Hospital. He is also the coordinator of the university department of development in health and care at Paul Sabatier University.
Member of several international learned societies, he has collaborated on more than 90 scientific articles of reference. Developing a strong clinical activity, he has always been on the lookout the latest innovations by combining his research activity and his proximity to patients.

At Usense, Dr. Ivan Tack guides the detection of biomarkers of medical interest and ensures that the technological solutions developed are aligned with the needs of practitioners.

"A few years ago, nephrology experienced its first revolution with the introduction of urine strips. Today, we are on the verge of a new revolution initiated by Usense that will affect not only nephrology but many other medical specialties. We are only at the beginning of exploring the study of urinary excretions, which represents a further step towards individualised medicine.

A cardiologist by training, Professor Philippe Douste-Blazy has served as Mayor of Lourdes and then of Toulouse, Minister of Health, Minister of Culture, Minister of Minister of Foreign Affairs and Deputy Secretary General of the United Nations, in charge of innovative financing for development. Founding President of Unitaid, a United Nations organization which negotiates the purchase of medicines for developing countries. Since 2020, he has been President of the United Nations Unitlife Fund, dedicated to the fight against malnutrition in the first 1,000 days of life.

Professor Philippe Douste-Blazy brings to Usense his expertise in clinical research, his knowledge of public health issues in France and internationally, and his experience in the in the dissemination of diagnostic and therapeutic innovations to the greatest number of people in the service of health for all.

"Usense is a perfect example of what tomorrow's medicine will be like. Medicine that is both preventive, facilitating instant diagnosis from urine, and and personalised medicine. It will improve the monitoring of the disease as close as possible to the patient. Usense will be a real opportunity for health systems including in the most remote areas where access to diagnosis is difficult or non-existent.

Dr Alain Pluquet holds a PhD in particle physics obtained at Fermilab (USA) and at the CEA (Commissariat à l'Energie Atomique). He has worked for 20 years at the CEA, where he oversaw the sensor and signal technologies department. He joined Biomérieux as a member of the Management Committee (CTO, CDO) and then became Vice President of Institut Merieux, in charge of technology and innovation

Dr. Alain Pluquet brings to Usense his multidisciplinary expertise combining biology, technology, entrepreneurship applied to the health field.

"The solutions developed by Usense fit perfectly with the evolution of healthcare systems in France and in the world. Thanks to a rapid, multiparametric, easy-to-use diagnostic tool, Usense contributes to to the optimisation of care paths in many medical situations.